In this Partner Interview, sponsored by Veeva Crossix, Rich Springham speaks with Jessica Daigle, Head of Crossix Audience Segments at Veeva, about why audience-first activation is becoming increasingly important as therapies become more complex and audiences harder to reach.
The conversation explores how marketers can activate audiences consistently across channels while balancing precision, reach and privacy. Jessica discusses the value of health-based targeting, platform-specific audience strategies and how combining audience activation with performance insights can help marketers continually refine their targeting.
Looking beyond DTC media, Jessica also explores the opportunity to synchronise HCP, consumer and field engagement. As pharma moves towards more connected customer experiences, putting the audience at the centre and coordinating DTC, HCP and field engagement will be increasingly important to achieving true omnichannel marketing.